Spinal Cord Ependymomas

  • Tom Kosztowski
  • Jared S. Fridley
  • Ziya L. GokaslanEmail author


Spinal cord ependymomas are a rare type of tumor that is most often low-grade. In this chapter, an overview of ependymomas of the spine is provided. The prevalence, biology, molecular genetics, presentation, diagnosis, and treatment are discussed.


Myxopapillary Ependymoma Anaplastic Ependymoma 


  1. 1.
    Chamberlain MC. Ependymomas. Curr Neurol Neurosci Rep. 2003;3(3):193–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Celano E, Salehani A, Malcolm JG, Reinertsen E, Hadjipanayis CG. Spinal cord ependymoma: a review of the literature and case series of ten patients. J Neuro-Oncol. 2016;128(3):377–86. Scholar
  3. 3.
    Schwartz TH, McCormick PC. Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neuro-Oncol. 2000;47(3):211–8.CrossRefGoogle Scholar
  4. 4.
    Mork SJ, Loken AC. Ependymoma: a follow-up study of 101 cases. Cancer. 1977;40(2):907–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Helseth A, Mork SJ (1989) Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J Neurosurg 71 (6):842–845.
  6. 6.
    McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990;72(4):523–32. Scholar
  7. 7.
    Epstein FJ, Farmer JP, Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg. 1993;79(2):204–9. Scholar
  8. 8.
    Hoshimaru M, Koyama T, Hashimoto N, Kikuchi H. Results of microsurgical treatment for intramedullary spinal cord ependymomas: analysis of 36 cases. Neurosurgery. 1999;44(2):264–9.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Cooper PR. Outcome after operative treatment of intramedullary spinal cord tumors in adults: intermediate and long-term results in 51 patients. Neurosurgery. 1989;25(6):855–9.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Marks JE, Adler SJ. A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys. 1982;8(1):37–43.PubMedCrossRefGoogle Scholar
  11. 11.
    Yamada CY, Whitman GJ, Chew FS. Myxopapillary ependymoma of the filum terminale. AJR Am J Roentgenol. 1997;168(2):366. Scholar
  12. 12.
    Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P, Kalifa C, French Society of Pediatric O. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001;19(5):1288–96. Scholar
  13. 13.
    Comi AM, Backstrom JW, Burger PC, Duffner PK. Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric oncology group. Pediatr Neurol. 1998;18(1):23–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, Lena G, Choux M, Pellissier JF. Prognostic factors in intracranial ependymomas in children. J Neurosurg. 2000;93(4):605–13. Scholar
  15. 15.
    Engelhard HH, Villano JL, Porter KR, Stewart AK, Barua M, Barker FG, Newton HB. Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina. J Neurosurg Spine. 2010;13(1):67–77. Scholar
  16. 16.
    Klekamp J. Spinal ependymomas. Part 1: intramedullary ependymomas. Neurosurg Focus. 2015;39(2):E6. Scholar
  17. 17.
    Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, Pollack IF, Prados MD, Robins HI, Soffietti R, Wu J, Miller CR, Gilbert MR, Aldape KD, Collaborative Ependymoma Research N. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol. 2013;23(5):584–94. Scholar
  18. 18.
    Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, Sayegh ET, Aranda D, Parsa AT. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro-Oncology. 2013;15(2):208–15. Scholar
  19. 19.
    Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery. 1996;39(1):135–40.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. Mod Pathol. 2005;18(7):991–7. Scholar
  21. 21.
    Santi M, Quezado M, Ronchetti R, Rushing EJ. Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization. J Neuro-Oncol. 2005;72(1):25–8. Scholar
  22. 22.
    Suzuki SO, Iwaki T. Amplification and overexpression of mdm2 gene in ependymomas. Mod Pathol. 2000;13(5):548–53. Scholar
  23. 23.
    Manasa LP, Uppin MS, Sundaram C. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma. Indian J Pathol Microbiol. 2012;55(3):308–13. Scholar
  24. 24.
    Kahan H, Sklar EM, Post MJ, Bruce JH. MR characteristics of histopathologic subtypes of spinal ependymoma. AJNR Am J Neuroradiol. 1996;17(1):143–50.Google Scholar
  25. 25.
    Wagle WA, Jaufman B, Mincy JE. Intradural extramedullary ependymoma: MR-pathologic correlation. J Comput Assist Tomogr. 1988;12(4):705–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics. 2000;20(6):1721–49. Scholar
  27. 27.
    Mineura K, Shioya H, Kowada M, Ogawa T, Hatazawa J, Uemura K. Subependymoma of the septum pellucidum: characterization by PET. J Neuro-Oncol. 1997;32(2):143–7.CrossRefGoogle Scholar
  28. 28.
    Paulino AC, Wen BC, Buatti JM, Hussey DH, Zhen WK, Mayr NA, Menezes AH. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002;25(2):117–22.PubMedCrossRefGoogle Scholar
  29. 29.
    Klekamp J. Spinal ependymomas. Part 2: Ependymomas of the filum terminale. Neurosurg Focus. 2015;39(2):E7. Scholar
  30. 30.
    Hanbali F, Fourney DR, Marmor E, Suki D, Rhines LD, Weinberg JS, McCutcheon IE, Suk I, Gokaslan ZL. Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery. 2002;51(5):1162–72. discussion 1172-1164PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Jeibmann A, Egensperger R, Kuchelmeister K, Sepehrnia A, Stolke D, Bruns B, Wassmann H, Ebel H, Paulus W, Hasselblatt M. Extent of surgical resection but not myxopapillary versus classical histopathological subtype affects prognosis in lumbo-sacral ependymomas. Histopathology. 2009;54(2):260–2. Scholar
  32. 32.
    Ohata K, Takami T, Gotou T, El-Bahy K, Morino M, Maeda M, Inoue Y, Hakuba A. Surgical outcome of intramedullary spinal cord ependymoma. Acta Neurochir. 1999;141(4):341–6. discussion 346-347PubMedCrossRefGoogle Scholar
  33. 33.
    Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, Mehta AI, Hardin C, Bagley CA, Isaacs RE, Haglund MM, Friedman AH. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurgery. 2015;76(Suppl 1):S4–13; discussion S13. Scholar
  34. 34.
    Joaquim AF, Santos MJ, Tedeschi H. Surgical management of intramedullary spinal ependymomas. Arq Neuropsiquiatr. 2009;67(2A):284–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Nagasawa DT, Smith ZA, Cremer N, Fong C, Lu DC, Yang I. Complications associated with the treatment for spinal ependymomas. Neurosurg Focus. 2011;31(4):E13. Scholar
  36. 36.
    Oh MC, Kim JM, Kaur G, Safaee M, Sun MZ, Singh A, Aranda D, Molinaro AM, Parsa AT. Prognosis by tumor location in adults with spinal ependymomas. J Neurosurg Spine. 2013;18(3):226–35. Scholar
  37. 37.
    Chang UK, Choe WJ, Chung SK, Chung CK, Kim HJ. Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults. J Neuro-Oncol. 2002;57(2):133–9.CrossRefGoogle Scholar
  38. 38.
    Oh MC, Tarapore PE, Kim JM, Sun MZ, Safaee M, Kaur G, Aranda DM, Parsa AT. Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci. 2013;20(10):1390–7. Scholar
  39. 39.
    Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, Kim KJ, Kim ES, Eoh W, Kim HJ. Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea spinal oncology research group. Neuro-Oncology. 2013;15(7):921–9. Scholar
  40. 40.
    Nakamura M, Tsuji O, Fujiyoshi K, Hosogane N, Watanabe K, Tsuji T, Ishii K, Toyama Y, Chiba K, Matsumoto M. Long-term surgical outcomes of spinal meningiomas. Spine. 2012;37(10):E617–23. Scholar
  41. 41.
    Nakamura M, Ishii K, Watanabe K, Tsuji T, Takaishi H, Matsumoto M, Toyama Y, Chiba K. Surgical treatment of intramedullary spinal cord tumors: prognosis and complications. Spinal Cord. 2008;46(4):282–6. Scholar
  42. 42.
    Kaner T, Sasani M, Oktenoglu T, Solmaz B, Sarloglu AC, Ozer AF. Clinical analysis of 21 cases of spinal cord ependymoma: positive clinical results of gross total resection. J Korean Neurosurg Soc. 2010;47(2):102–6. Scholar
  43. 43.
    Peker S, Ozgen S, Ozek MM, Pamir MN. Surgical treatment of intramedullary spinal cord ependymomas: can outcome be predicted by tumor parameters? J Spinal Disord Tech. 2004;17(6):516–21.PubMedCrossRefGoogle Scholar
  44. 44.
    Bostrom A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Bostrom JP, Schramm J, Simon M. Surgery for spinal cord ependymomas: outcome and prognostic factors. Neurosurgery. 2011;68(2):302–8.; discussion 309. Scholar
  45. 45.
    Bagley CA, Wilson S, Kothbauer KF, Bookland MJ, Epstein F, Jallo GI. Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev. 2009;32(3):321–34.; discussion 334. Scholar
  46. 46.
    Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, Lied B, Ronning P, Skaar S, Spetalen S, Helseth E. Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery. 2010;67(6):1622–31.; discussion 1631. Scholar
  47. 47.
    Nakamura M, Ishii K, Watanabe K, Tsuji T, Matsumoto M, Toyama Y, Chiba K. Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina. Spine. 2009;34(21):E756–60. Scholar
  48. 48.
    Abdulaziz M, Mallory GW, Bydon M, De la Garza RR, Ellis JA, Laack NN, Marsh WR, Krauss WE, Jallo G, Gokaslan ZL, Clarke MJ. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity. Neurosurg Focus. 2015;39(2):E8.
  49. 49.
    Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery. 1991;28(5):666–71. discussion 671-662PubMedCrossRefGoogle Scholar
  50. 50.
    Clover LL, Hazuka MB, Kinzie JJ. Spinal cord ependymomas treated with surgery and radiation therapy. A review of 11 cases. Am J Clin Oncol. 1993;16(4):350–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J Neuro-Oncol. 2000;47(3):231–8.CrossRefGoogle Scholar
  52. 52.
    Ryu SI, Kim DH, Chang SD. Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus. 2003;15(5):E10.PubMedGoogle Scholar
  53. 53.
    Amsbaugh MJ, Grosshans DR, McAleer MF, Zhu R, Wages C, Crawford CN, Palmer M, De Gracia B, Woo S, Mahajan A. Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys. 2012;83(5):1419–24. Scholar
  54. 54.
    Chamberlain MC. Etoposide for recurrent spinal cord ependymoma. Neurology. 2002;58(8):1310–1.PubMedCrossRefGoogle Scholar
  55. 55.
    Chamberlain MC. Salvage chemotherapy for recurrent spinal cord ependymona. Cancer. 2002;95(5):997–1002. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Tom Kosztowski
    • 1
  • Jared S. Fridley
    • 1
  • Ziya L. Gokaslan
    • 1
    Email author
  1. 1.Department of NeurosurgeryWarren Alpert School of Medicine at Brown University, Rhode Island HospitalProvidenceUSA

Personalised recommendations